| Field | Row 1 |
|---|---|
| adsh | 0001599298-25-000089 |
| cik | 1599298 |
| name | SUMMIT THERAPEUTICS INC. |
| sic | 2834 |
| countryba | US |
| stprba | FL |
| cityba | MIAMI |
| zipba | 33131 |
| bas1 | 601 BRICKELL KEY DRIVE |
| bas2 | SUITE 1000 |
| baph | 305-203-2034 |
| countryma | US |
| stprma | FL |
| cityma | MIAMI |
| zipma | 33131 |
| mas1 | 601 BRICKELL KEY DRIVE |
| mas2 | SUITE 1000 |
| countryinc | |
| stprinc | |
| ein | 371979717 |
| former | SUMMIT THERAPEUTICS PLC |
| changed | 20150219 |
| afs | 1-LAF |
| wksi | 0 |
| fye | 1231 |
| form | 10-Q |
| period | 20250331 |
| fy | 2025 |
| fp | Q1 |
| filed | 20250501 |
| accepted | 2025-05-01 16:12:00.0 |
| prevrpt | 0 |
| detail | 1 |
| instance | smmt-20250331_htm.xml |
| nciks | 1 |
| aciks |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| cik | Central Index Key (CIK). Ten digit number assigned by the SEC to each registrant that submits filings. |
| name | Name of registrant. This corresponds to the name of the legal entity as recorded in EDGAR as of the filing date. |
| sic | Standard Industrial Classification (SIC). Four digit code assigned by the SEC as of the filing date, indicating the registrant’s type of business. |
| countryba | The ISO 3166-1 country of the registrant's business address. |
| stprba | The state or province of the registrant’s business address, if field countryba is US or CA. |
| cityba | The city of the registrant's business address. |
| zipba | The zip code of the registrant’s business address. |
| bas1 | The first line of the street of the registrant’s business address. |
| bas2 | The second line of the street of the registrant’s business address. |
| baph | The phone number of the registrant’s business address. |
| countryma | The ISO 3166-1 country of the registrant's mailing address. |
| stprma | The state or province of the registrant’s mailing address, if field countryma is US or CA. |
| cityma | The city of the registrant's mailing address. |
| zipma | The zip code of the registrant’s mailing address. |
| mas1 | The first line of the street of the registrant’s mailing address. |
| mas2 | The second line of the street of the registrant’s mailing address. |
| countryinc | The ISO 3166-1 country of incorporation for the registrant. |
| stprinc | The state or province of incorporation for the registrant, if countryinc is US or CA. |
| ein | Employee Identification Number, 9 digit identification number assigned by the Internal Revenue Service to business entities operating in the United States. |
| former | Most recent former name of the registrant, if any. |
| changed | Date of change from the former name, if any. |
| afs | Filer status with the SEC at the time of submission: 1-LAF=Large Accelerated, 2-ACC=Accelerated, 3-SRA=Smaller Reporting Accelerated, 4-NON=Non-Accelerated, 5-SML=Smaller Reporting Filer, NULL=not assigned. |
| wksi | Well Known Seasoned Issuer (WKSI). An issuer that meets specific SEC requirements at some point during a 60-day period preceding the date the issuer satisfies its obligation to update its shelf registration statement. |
| fye | Fiscal Year End Date, rounded to nearest month-end. |
| form | The submission type of the registrant’s filing. |
| period | Balance Sheet Date, rounded to nearest month-end. |
| fy | Fiscal Year Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8). |
| fp | Fiscal Period Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8) within Fiscal Year. |
| filed | The date of the registrant’s filing with the Commission. |
| accepted | The acceptance date and time of the registrant’s filing with the Commission. |
| prevrpt | Previous Report – TRUE indicates that the submission information was subsequently amended. |
| detail | TRUE indicates that the XBRL submission contains quantitative disclosures within the footnotes and schedules at the required detail level (e.g., each amount). |
| instance | The name of the submitted XBRL Instance Document. The name often begins with the company ticker symbol. |
| nciks | Number of Central Index Keys (CIK) of registrants (i.e., business units) included in the consolidating entity’s submitted filing. |
| aciks | Additional CIKs of co-registrants included in a consolidating entity’s EDGAR submission, separated by spaces. If there are no other co-registrants (i.e., nciks=1), the value of aciks is NULL. For a very small number of filers, the entire list of co-registrants is too long to fit in the field. Where this is the case, users should refer to the complete submission file for all CIK information. |
| adsh | ddate | tag | value | uom | qtrs | version | segments | coreg | footnote |
|---|---|---|---|---|---|---|---|---|---|
| 0001599298-25-000089 | 20250331 | Accumulated Other Comprehensive Income Loss Net Of Tax | -2563000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20250331 | Accretion Amortization Of Discounts And Premiums Investments | 2966000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20250331 | Accrued Liabilities Current | 21185000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20250331 | Accrued Liabilities Current | 3914000.0000 | USD | 0 | us-gaap/2024 | Related Party Transaction= Akeso Supply Agreement; Related Party Transactions By Related Party= Related Party; | ||
| 0001599298-25-000089 | 20241231 | Additional Paid In Capital | 1598230000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20241231 | Commitments And Contingencies | USD | 0 | us-gaap/2024 | ||||
| 0001599298-25-000089 | 20221130 | Common Stock Par Or Stated Value Per Share | 0.0100 | USD | 0 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20241231 | Common Stock Par Or Stated Value Per Share | 0.0100 | USD | 0 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20241231 | Employee Related Liabilities Current | 11977000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20240331 | General And Administrative Expense | 11516000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20250331 | Increase Decrease In Accounts Payable | 356000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20250331 | Interest Paid Net | 0.0000 | USD | 1 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20241231 | Liabilities Current | 41729000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20241231 | Operating Lease Right Of Use Asset | 7144000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20240331 | Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax | -12000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20240331 | Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | -1000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20250331 | Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | -278000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001599298-25-000089 | 20250331 | Other Liabilities Noncurrent | 1708000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20240331 | Payments To Acquire Short Term Investments | 92982000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20250331 | Preferred Stock Shares Issued | 0.0000 | shares | 0 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20241231 | Preferred Stock Shares Outstanding | 0.0000 | shares | 0 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20250331 | Proceeds From Sale Maturity And Collection Of Shortterm Investments | 160532000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20241231 | Property Plant And Equipment Net | 254000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20250331 | Property Plant And Equipment Net | 652000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20250331 | Retained Earnings Accumulated Deficit | -1277486000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20250331 | Share Based Compensation | 11096000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20240331 | Stockholders Equity | 44210000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20250331 | Stock Issued During Period Value Share Based Compensation | 7677000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20240331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 9507000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001599298-25-000089 | 20250331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 11096000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20241231 | Common Stock Shares Authorized | 1000000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20241231 | Common Stock Shares Issued | 737626004.0000 | shares | 0 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20231231 | Common Stock Shares Outstanding | 701660053.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001599298-25-000089 | 20240331 | Common Stock Shares Outstanding | 701974596.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001599298-25-000089 | 20241231 | Common Stock Shares Outstanding | 737626004.0000 | shares | 0 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20241231 | Common Stock Value | 7376000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20240331 | Comprehensive Income Net Of Tax | -43474000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20250331 | General And Administrative Expense | 15586000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20240331 | Increase Decrease In Other Current Liabilities | 97000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20250331 | Liabilities Current | 34877000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20250331 | Net Cash Provided By Used In Financing Activities | 7677000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20240331 | Net Cash Provided By Used In Operating Activities | -30134000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20240331 | Net Income Loss | -43473000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20250331 | Operating Expenses | 66851000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Reportable Segment; | ||
| 0001599298-25-000089 | 20241231 | Other Assets Noncurrent | 2548000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20250331 | Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax | -133000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20250331 | Preferred Stock Shares Outstanding | 0.0000 | shares | 0 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20240331 | Proceeds From Warrant Exercises | 0.0000 | USD | 1 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20250331 | Proceeds From Warrant Exercises | 5658000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20241231 | Short Term Investments | 307487000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20250331 | Short Term Investments | 149789000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20231231 | Stockholders Equity | -993258000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001599298-25-000089 | 20240331 | Stockholders Equity | -2449000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001599298-25-000089 | 20240331 | Stockholders Equity | 7020000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001599298-25-000089 | 20241231 | Stockholders Equity | -2285000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001599298-25-000089 | 20241231 | Stockholders Equity | 1598230000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001599298-25-000089 | 20250331 | Stockholders Equity | 7416000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001599298-25-000089 | 20250331 | Weighted Average Number Of Shares Outstanding Basic | 738076003.0000 | shares | 1 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20240331 | Accretion Amortization Of Discounts And Premiums Investments | 402000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20250331 | Assets | 383822000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20231231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 71425000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20250331 | Common Stock Par Or Stated Value Per Share | 0.0100 | USD | 0 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20240331 | Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | -36000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20240331 | Increase Decrease In Other Noncurrent Assets | -2446000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20240331 | Increase Decrease In Other Noncurrent Liabilities | 1740000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20250331 | Increase Decrease In Prepaid Deferred Expense And Other Assets | -1850000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20240331 | Interest Expense Nonoperating | 3121000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20250331 | Interest Expense Nonoperating | 0.0000 | USD | 1 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20241231 | Liabilities And Stockholders Equity | 435560000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20250331 | Net Income Loss | -62913000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001599298-25-000089 | 20240331 | Operating Expenses | 42389000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20241231 | Operating Lease Liability Noncurrent | 3453000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20241231 | Other Liabilities Noncurrent | 1630000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20250331 | Payments To Acquire Property Plant And Equipment | 422000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20241231 | Preferred Stock Shares Authorized | 20000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20240331 | Research And Development Expense Excluding Acquired In Process Cost | 30873000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20250331 | Research And Development Expense Excluding Acquired In Process Cost | 51265000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20241231 | Retained Earnings Accumulated Deficit | -1214573000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20250331 | Stockholders Equity | 344330000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20250331 | Weighted Average Number Of Diluted Shares Outstanding | 738076003.0000 | shares | 1 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20241231 | Accumulated Other Comprehensive Income Loss Net Of Tax | -2285000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20240331 | Cash And Cash Equivalents At Carrying Value | 61294000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20250331 | Cash And Cash Equivalents At Carrying Value | 211526000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -9814000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | 106657000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20250331 | Common Stock Shares Authorized | 1000000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20250331 | Common Stock Shares Issued | 741609390.0000 | shares | 0 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20241231 | Common Stock Shares Outstanding | 737626004.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001599298-25-000089 | 20240331 | Earnings Per Share Basic | -0.0600 | USD | 1 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20250331 | Foreign Currency Transaction Gain Loss Unrealized | 224000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20241231 | Goodwill | 1864000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20240331 | Increase Decrease In Accrued Liabilities | -2228000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20240331 | Increase Decrease In Operating Lease Liability | -92000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20250331 | Increase Decrease In Other Noncurrent Assets | 1419000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20240331 | Interest Paid Net | 1501000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20241231 | Liabilities | 46812000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20250331 | Liabilities | 39492000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20240331 | Net Cash Provided By Used In Investing Activities | 19871000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20250331 | Net Cash Provided By Used In Operating Activities | -61168000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20240331 | Nonoperating Income Expense | 2037000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Reportable Segment; | ||
| 0001599298-25-000089 | 20241231 | Operating Lease Liability Current | 3765000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20240331 | Payments To Acquire Property Plant And Equipment | 4000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20250331 | Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options | 2019000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20250331 | Right Of Use Asset Obtained In Exchange For Operating Lease Liability | 0.0000 | USD | 1 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20231231 | Stockholders Equity | 7017000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001599298-25-000089 | 20240331 | Stockholders Equity | 1076370000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001599298-25-000089 | 20250331 | Stockholders Equity | -1277486000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001599298-25-000089 | 20240331 | Stock Issued During Period Value Share Based Compensation | 485000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20250331 | Stock Issued During Period Value Share Based Compensation | 7637000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001599298-25-000089 | 20250331 | Stock Issued During Period Value Share Based Compensation | 40000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001599298-25-000089 | 20240331 | Weighted Average Number Of Diluted Shares Outstanding | 701785250.0000 | shares | 1 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20241231 | Accrued Liabilities Current | 19554000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20250331 | Accounts Payable Current | 4994000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20241231 | Cash And Cash Equivalents At Carrying Value | 104862000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20241231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 105187000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20240331 | Earnings Per Share Diluted | -0.0600 | USD | 1 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20250331 | Employee Related Liabilities Current | 4396000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20240331 | Increase Decrease In Accounts Payable | 3704000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20240331 | Increase Decrease In Employee Related Liabilities | 606000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20250331 | Increase Decrease In Employee Related Liabilities | -7588000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20250331 | Increase Decrease In Other Noncurrent Liabilities | 25000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20240930 | Interest Paid Net | 7305000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20250331 | Net Cash Provided By Used In Investing Activities | 160110000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20250331 | Net Income Loss | -62913000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20250331 | Net Income Loss | -62913000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Reportable Segment; | ||
| 0001599298-25-000089 | 20250331 | Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax | -145000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20250331 | Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | -278000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20241231 | Preferred Stock Par Or Stated Value Per Share | 0.0100 | USD | 0 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20250331 | Preferred Stock Value | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20250331 | Prepaid Expense And Other Assets Current | 9118000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20241231 | Restricted Cash Current | 325000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20240331 | Right Of Use Asset Obtained In Exchange For Operating Lease Liability | 4216000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20231231 | Stockholders Equity | -2448000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001599298-25-000089 | 20231231 | Stockholders Equity | 1066381000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001599298-25-000089 | 20240331 | Stockholders Equity | -1036731000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001599298-25-000089 | 20241231 | Stockholders Equity | 388748000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20250331 | Stock Issued During Period Shares Share Based Compensation | 3983386.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001599298-25-000089 | 20241231 | Accounts Payable Current | 4636000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20241231 | Accrued Liabilities Current | 3956000.0000 | USD | 0 | us-gaap/2024 | Related Party Transaction= Akeso Supply Agreement; Related Party Transactions By Related Party= Related Party; | ||
| 0001599298-25-000089 | 20250331 | Additional Paid In Capital | 1616963000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20250331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 11096000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001599298-25-000089 | 20250331 | Commitments And Contingencies | USD | 0 | us-gaap/2024 | ||||
| 0001599298-25-000089 | 20250331 | Common Stock Shares Outstanding | 741609390.0000 | shares | 0 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20240331 | Depreciation | 27000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20250331 | Earnings Per Share Diluted | -0.0900 | USD | 1 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20250331 | Goodwill | 1923000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20250331 | Increase Decrease In Other Current Liabilities | -1046000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20240331 | Increase Decrease In Prepaid Deferred Expense And Other Assets | 2075000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20240331 | Net Cash Provided By Used In Financing Activities | 485000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20240331 | Net Income Loss | -43473000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Reportable Segment; | ||
| 0001599298-25-000089 | 20250331 | Operating Expenses | 66851000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20250331 | Operating Lease Liability Current | 3543000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20250331 | Other Assets Noncurrent | 4145000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20240331 | Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | -1000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001599298-25-000089 | 20241231 | Prepaid Expense And Other Assets Current | 11076000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20240331 | Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options | 485000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20241231 | Stockholders Equity | -1214573000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001599298-25-000089 | 20240331 | Stock Issued During Period Value Share Based Compensation | 482000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001599298-25-000089 | 20241231 | Assets | 435560000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20250331 | Assets Current | 370751000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 61611000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20250331 | Common Stock Value | 7416000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20250331 | Increase Decrease In Operating Lease Liability | 25000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20250331 | Interest Expense Nonoperating | 0.0000 | USD | 1 | us-gaap/2024 | Business Segments= Reportable Segment; | ||
| 0001599298-25-000089 | 20240331 | Nonoperating Income Expense | 2037000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20250331 | Nonoperating Income Expense | 3938000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Reportable Segment; | ||
| 0001599298-25-000089 | 20250331 | Operating Lease Right Of Use Asset | 6351000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20240331 | Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax | 11000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20241231 | Other Liabilities Current | 1797000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20250331 | Other Liabilities Current | 759000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20250331 | Preferred Stock Shares Authorized | 20000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20241231 | Preferred Stock Value | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20240331 | Proceeds From Sale Maturity And Collection Of Shortterm Investments | 112857000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20240331 | Research And Development Expense Excluding Acquired In Process Cost | 21897000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Reportable Segment; | ||
| 0001599298-25-000089 | 20240331 | Share Based Compensation | 9507000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20231231 | Stockholders Equity | 77692000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20241231 | Stockholders Equity | 7376000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001599298-25-000089 | 20250331 | Stockholders Equity | -2563000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001599298-25-000089 | 20250331 | Stockholders Equity | 1616963000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001599298-25-000089 | 20240331 | Stock Issued During Period Value Share Based Compensation | 3000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001599298-25-000089 | 20250331 | Depreciation | 25000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20250331 | Comprehensive Income Net Of Tax | -63191000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20240331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 9507000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20241231 | Assets Current | 423750000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 211844000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20250331 | Common Stock Shares Outstanding | 741609390.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001599298-25-000089 | 20250331 | Earnings Per Share Basic | -0.0900 | USD | 1 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20250331 | Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 38000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20240331 | Foreign Currency Transaction Gain Loss Unrealized | -9000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20250331 | Increase Decrease In Accrued Liabilities | 1611000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20240331 | Interest Expense Nonoperating | 3121000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Reportable Segment; | ||
| 0001599298-25-000089 | 20250331 | Liabilities And Stockholders Equity | 383822000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20240331 | Net Income Loss | -43473000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001599298-25-000089 | 20250331 | Nonoperating Income Expense | 3938000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20240331 | Operating Expenses | 42389000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Reportable Segment; | ||
| 0001599298-25-000089 | 20250331 | Operating Lease Liability Noncurrent | 2907000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20250331 | Payments To Acquire Short Term Investments | 0.0000 | USD | 1 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20250331 | Preferred Stock Par Or Stated Value Per Share | 0.0100 | USD | 0 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20241231 | Preferred Stock Shares Issued | 0.0000 | shares | 0 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20250331 | Research And Development Expense Excluding Acquired In Process Cost | 36363000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Reportable Segment; | ||
| 0001599298-25-000089 | 20240331 | Restricted Cash Current | 317000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20250331 | Restricted Cash Current | 318000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001599298-25-000089 | 20240331 | Stock Issued During Period Shares Share Based Compensation | 314543.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001599298-25-000089 | 20240331 | Weighted Average Number Of Shares Outstanding Basic | 701785250.0000 | shares | 1 | us-gaap/2024 |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| ddate | The end date for the data value, rounded to the nearest month end. |
| qtrs | The count of the number of quarters represented by the data value, rounded to the nearest whole number. “0” indicates it is a point-in-time value. |
| uom | The unit of measure for the value. |
| segments | Tags used to represent axis and member reporting. |
| coreg | If specified, indicates a specific co-registrant, the parent company, or other entity (e.g., guarantor). NULL indicates the consolidated entity. |
| value | The value. This is not scaled, it is as found in the Interactive Data file, but is limited to four digits to the right of the decimal point. |
| footnote | The text of any superscripted footnotes on the value, as shown on the statement page, truncated to 512 characters, or if there is no footnote, then this field will be blank. |
| tag | version | custom | abstract | datatype | iord | crdr | tlabel | doc |
|---|---|---|---|---|---|---|---|---|
| Assets Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Assets, Current | Amount of asset recognized for present right to economic benefit, classified as current. |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | 0 | 0 | monetary | I | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents | Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Increase Decrease In Other Noncurrent Assets | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Other Noncurrent Assets | Amount of increase (decrease) in noncurrent assets classified as other. |
| Operating Lease Liability Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Operating Lease, Liability, Current | Present value of lessee's discounted obligation for lease payments from operating lease, classified as current. |
| Payments To Acquire Property Plant And Equipment | us-gaap/2024 | 0 | 0 | monetary | D | C | Payments to Acquire Property, Plant, and Equipment | The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets. |
| Right Of Use Asset Obtained In Exchange For Operating Lease Liability | us-gaap/2024 | 0 | 0 | monetary | D | D | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability | Amount of increase in right-of-use asset obtained in exchange for operating lease liability. |
| Comprehensive Income Net Of Tax | us-gaap/2024 | 0 | 0 | monetary | D | C | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners. |
| Liabilities | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities | Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others. |
| Liabilities And Stockholders Equity | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities and Equity | Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. |
| Retained Earnings Accumulated Deficit | us-gaap/2024 | 0 | 0 | monetary | I | C | Retained Earnings (Accumulated Deficit) | Amount of accumulated undistributed earnings (deficit). |
| Short Term Investments | us-gaap/2024 | 0 | 0 | monetary | I | D | Short-Term Investments | Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current. |
| Additional Paid In Capital | us-gaap/2024 | 0 | 0 | monetary | I | C | Additional Paid in Capital | Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock. |
| Common Stock Par Or Stated Value Per Share | us-gaap/2024 | 0 | 0 | perShare | I | Common Stock, Par or Stated Value Per Share | Face amount or stated value per share of common stock. | |
| Common Stock Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares, Outstanding | Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. | |
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | us-gaap/2024 | 0 | 0 | monetary | D | D | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Net Income Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Net Income (Loss) Attributable to Parent | The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. |
| Restricted Cash Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Restricted Cash, Current | Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. |
| Stockholders Equity | us-gaap/2024 | 0 | 0 | monetary | I | C | Equity, Attributable to Parent | Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest. |
| Stock Issued During Period Value Share Based Compensation | us-gaap/2024 | 0 | 0 | monetary | D | C | Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture | Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP). |
| Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Diluted | The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. | |
| Accumulated Other Comprehensive Income Loss Net Of Tax | us-gaap/2024 | 0 | 0 | monetary | I | C | Accumulated Other Comprehensive Income (Loss), Net of Tax | Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source. |
| Assets | us-gaap/2024 | 0 | 0 | monetary | I | D | Assets | Amount of asset recognized for present right to economic benefit. |
| Common Stock Shares Issued | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares, Issued | Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. | |
| Earnings Per Share Diluted | us-gaap/2024 | 0 | 0 | perShare | D | Earnings Per Share, Diluted | The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. | |
| Foreign Currency Transaction Gain Loss Unrealized | us-gaap/2024 | 0 | 0 | monetary | D | C | Unrealized Gain (Loss), Foreign Currency Transaction, before Tax | Amount, before tax, of unrealized gain (loss) from foreign currency transaction. |
| Operating Lease Right Of Use Asset | us-gaap/2024 | 0 | 0 | monetary | I | D | Operating Lease, Right-of-Use Asset | Amount of lessee's right to use underlying asset under operating lease. |
| Other Assets Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | D | Other Assets, Noncurrent | Amount of noncurrent assets classified as other. |
| Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax | us-gaap/2024 | 0 | 0 | monetary | D | C | OCI, Debt Securities, Available-for-Sale, Gain (Loss), before Adjustment, after Tax | Amount, after tax and before adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale. |
| Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Including Option Exercised | Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised. |
| Accrued Liabilities Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Accrued Liabilities, Current | Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). |
| Interest Expense Nonoperating | us-gaap/2024 | 0 | 0 | monetary | D | D | Interest Expense, Nonoperating | Amount of interest expense classified as nonoperating. |
| Liabilities Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities, Current | Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. |
| Preferred Stock Shares Issued | us-gaap/2024 | 0 | 0 | shares | I | Preferred Stock, Shares Issued | Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt. | |
| Research And Development Expense Excluding Acquired In Process Cost | us-gaap/2024 | 0 | 0 | monetary | D | D | Research and Development Expense (Excluding Acquired in Process Cost) | Amount of expense for research and development. Excludes cost for computer software product to be sold, leased, or otherwise marketed, writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both, and write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. |
| Share Based Compensation | us-gaap/2024 | 0 | 0 | monetary | D | D | Share-Based Payment Arrangement, Noncash Expense | Amount of noncash expense for share-based payment arrangement. |
| Cash And Cash Equivalents At Carrying Value | us-gaap/2024 | 0 | 0 | monetary | I | D | Cash and Cash Equivalents, at Carrying Value | Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. |
| Increase Decrease In Employee Related Liabilities | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Employee Related Liabilities | The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. |
| Increase Decrease In Other Current Liabilities | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Other Current Liabilities | Amount of increase (decrease) in current liabilities classified as other. |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Prepaid Expense and Other Assets | Amount of increase (decrease) in prepaid expenses, and assets classified as other. |
| Other Liabilities Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Other Liabilities, Current | Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer. |
| Nonoperating Income Expense | us-gaap/2024 | 0 | 0 | monetary | D | C | Nonoperating Income (Expense) | The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). |
| Proceeds From Sale Maturity And Collection Of Shortterm Investments | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from Sale, Maturity and Collection of Short-Term Investments | The cash inflow from sales, maturities, prepayments, calls and collections of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term. |
| Preferred Stock Value | us-gaap/2024 | 0 | 0 | monetary | I | C | Preferred Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity. |
| Common Stock Value | us-gaap/2024 | 0 | 0 | monetary | I | C | Common Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. |
| Employee Related Liabilities Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Employee-related Liabilities, Current | Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). |
| Goodwill | us-gaap/2024 | 0 | 0 | monetary | I | D | Goodwill | Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized. |
| Net Cash Provided By Used In Operating Activities | us-gaap/2024 | 0 | 0 | monetary | D | Net Cash Provided by (Used in) Operating Activities | Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. | |
| Operating Expenses | us-gaap/2024 | 0 | 0 | monetary | D | D | Operating Expenses | Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. |
| Other Liabilities Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | C | Other Liabilities, Noncurrent | Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer. |
| Prepaid Expense And Other Assets Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Prepaid Expense and Other Assets, Current | Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer. |
| General And Administrative Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | General and Administrative Expense | The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. |
| Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | us-gaap/2024 | 0 | 0 | monetary | D | C | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent | Amount after tax of other comprehensive income (loss) attributable to parent entity. |
| Accounts Payable Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Accounts Payable, Current | Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | us-gaap/2024 | 0 | 0 | monetary | D | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Commitments And Contingencies | us-gaap/2024 | 0 | 0 | monetary | I | C | Commitments and Contingencies | Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur. |
| Common Stock Shares Authorized | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares Authorized | The maximum number of common shares permitted to be issued by an entity's charter and bylaws. | |
| Increase Decrease In Accounts Payable | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Accounts Payable | The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. |
| Increase Decrease In Operating Lease Liability | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Operating Lease Liability | Amount of increase (decrease) in obligation for operating lease. |
| Interest Paid Net | us-gaap/2024 | 0 | 0 | monetary | D | C | Interest Paid, Excluding Capitalized Interest, Operating Activities | Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount. |
| Net Cash Provided By Used In Financing Activities | us-gaap/2024 | 0 | 0 | monetary | D | D | Net Cash Provided by (Used in) Financing Activities | Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. |
| Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax | us-gaap/2024 | 0 | 0 | monetary | D | C | Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax | Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature. |
| Preferred Stock Par Or Stated Value Per Share | us-gaap/2024 | 0 | 0 | perShare | I | Preferred Stock, Par or Stated Value Per Share | Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer. | |
| Accretion Amortization Of Discounts And Premiums Investments | us-gaap/2024 | 0 | 0 | monetary | D | C | Accretion (Amortization) of Discounts and Premiums, Investments | The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method. |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | us-gaap/2024 | 0 | 0 | monetary | D | C | APIC, Share-Based Payment Arrangement, Increase for Cost Recognition | Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement. |
| Depreciation | us-gaap/2024 | 0 | 0 | monetary | D | D | Depreciation | The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation. |
| Earnings Per Share Basic | us-gaap/2024 | 0 | 0 | perShare | D | Earnings Per Share, Basic | The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. | |
| Net Cash Provided By Used In Investing Activities | us-gaap/2024 | 0 | 0 | monetary | D | D | Net Cash Provided by (Used in) Investing Activities | Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets. |
| Preferred Stock Shares Authorized | us-gaap/2024 | 0 | 0 | shares | I | Preferred Stock, Shares Authorized | The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws. | |
| Preferred Stock Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Preferred Stock, Shares Outstanding | Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased. | |
| Increase Decrease In Accrued Liabilities | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Accrued Liabilities | The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid. |
| Increase Decrease In Other Noncurrent Liabilities | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Other Noncurrent Liabilities | Amount of increase (decrease) in noncurrent operating liabilities classified as other. |
| Operating Lease Liability Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | C | Operating Lease, Liability, Noncurrent | Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent. |
| Payments To Acquire Short Term Investments | us-gaap/2024 | 0 | 0 | monetary | D | C | Payments to Acquire Short-Term Investments | The cash outflow for securities or other assets acquired, which qualify for treatment as an investing activity and are to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term. |
| Proceeds From Warrant Exercises | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from Warrant Exercises | The cash inflow associated with the amount received from holders exercising their stock warrants. |
| Property Plant And Equipment Net | us-gaap/2024 | 0 | 0 | monetary | I | D | Property, Plant and Equipment, Net | Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. |
| Stock Issued During Period Shares Share Based Compensation | us-gaap/2024 | 0 | 0 | shares | D | Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture | Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP). | |
| Weighted Average Number Of Shares Outstanding Basic | us-gaap/2024 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Basic | Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. |
| Field Name | Field Description |
|---|---|
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| custom | 1 if tag is custom (version=adsh), 0 if it is standard. Note: This flag is technically redundant with the version and adsh columns. |
| abstract | 1 if the tag is not used to represent a numeric fact. |
| datatype | If abstract=1, then NULL, otherwise the data type (e.g., monetary) for the tag. |
| iord | If abstract=1, then NULL; otherwise, “I” if the value is a point-in time, or “D” if the value is a duration. |
| crdr | If datatype = monetary, then the tag’s natural accounting balance (debit or credit); if not defined, then NULL. |
| tlabel | If a standard tag, then the label text provided by the taxonomy, otherwise the text provided by the filer. A tag which had neither would have a NULL value here. |
| doc | The detailed definition for the tag. If a standard tag, then the text provided by the taxonomy, otherwise the text assigned by the filer. Some tags have neither, and this field is NULL. |
| adsh | report | line | stmt | inpth | rfile | tag | version | plabel | negating |
|---|---|---|---|---|---|---|---|---|---|
| 0001599298-25-000089 | 2 | 3 | BS | 0 | H | Cash And Cash Equivalents At Carrying Value | us-gaap/2024 | Cash and cash equivalents | 0 |
| 0001599298-25-000089 | 2 | 4 | BS | 0 | H | Restricted Cash Current | us-gaap/2024 | Restricted cash | 0 |
| 0001599298-25-000089 | 2 | 5 | BS | 0 | H | Short Term Investments | us-gaap/2024 | Short-term investments | 0 |
| 0001599298-25-000089 | 2 | 6 | BS | 0 | H | Prepaid Expense And Other Assets Current | us-gaap/2024 | Prepaid expenses and other current assets | 0 |
| 0001599298-25-000089 | 2 | 7 | BS | 0 | H | Assets Current | us-gaap/2024 | Total current assets | 0 |
| 0001599298-25-000089 | 2 | 9 | BS | 0 | H | Property Plant And Equipment Net | us-gaap/2024 | Property and equipment, net | 0 |
| 0001599298-25-000089 | 2 | 10 | BS | 0 | H | Operating Lease Right Of Use Asset | us-gaap/2024 | Operating lease right-of-use assets | 0 |
| 0001599298-25-000089 | 2 | 11 | BS | 0 | H | Goodwill | us-gaap/2024 | Goodwill | 0 |
| 0001599298-25-000089 | 2 | 12 | BS | 0 | H | Other Assets Noncurrent | us-gaap/2024 | Other assets | 0 |
| 0001599298-25-000089 | 2 | 13 | BS | 0 | H | Assets | us-gaap/2024 | Total assets | 0 |
| 0001599298-25-000089 | 2 | 16 | BS | 0 | H | Accounts Payable Current | us-gaap/2024 | Accounts payable | 0 |
| 0001599298-25-000089 | 2 | 17 | BS | 0 | H | Accrued Liabilities Current | us-gaap/2024 | Accrued liabilities | 0 |
| 0001599298-25-000089 | 2 | 18 | BS | 0 | H | Employee Related Liabilities Current | us-gaap/2024 | Accrued compensation | 0 |
| 0001599298-25-000089 | 2 | 19 | BS | 0 | H | Operating Lease Liability Current | us-gaap/2024 | Operating lease liabilities, current portion | 0 |
| 0001599298-25-000089 | 2 | 20 | BS | 0 | H | Other Liabilities Current | us-gaap/2024 | Other current liabilities | 0 |
| 0001599298-25-000089 | 2 | 21 | BS | 0 | H | Liabilities Current | us-gaap/2024 | Total current liabilities | 0 |
| 0001599298-25-000089 | 2 | 23 | BS | 0 | H | Operating Lease Liability Noncurrent | us-gaap/2024 | Operating lease liabilities, net of current portion | 0 |
| 0001599298-25-000089 | 2 | 24 | BS | 0 | H | Other Liabilities Noncurrent | us-gaap/2024 | Other non-current liabilities | 0 |
| 0001599298-25-000089 | 2 | 25 | BS | 0 | H | Liabilities | us-gaap/2024 | Total liabilities | 0 |
| 0001599298-25-000089 | 2 | 26 | BS | 0 | H | Commitments And Contingencies | us-gaap/2024 | Commitments and contingencies (Note 13) | 0 |
| 0001599298-25-000089 | 2 | 28 | BS | 0 | H | Preferred Stock Value | us-gaap/2024 | Preferred stock, $0.01 par value, 20,000,000 shares authorized; none issued and outstanding at March 31, 2025 and December 31, 2024, respectively | 0 |
| 0001599298-25-000089 | 2 | 29 | BS | 0 | H | Common Stock Value | us-gaap/2024 | Common stock, $0.01 par value: 1,000,000,000 shares authorized; 741,609,390 and 737,626,004 shares issued and outstanding at March 31, 2025 and December 31, 2024, respectively | 0 |
| 0001599298-25-000089 | 2 | 30 | BS | 0 | H | Additional Paid In Capital | us-gaap/2024 | Additional paid-in capital | 0 |
| 0001599298-25-000089 | 2 | 31 | BS | 0 | H | Accumulated Other Comprehensive Income Loss Net Of Tax | us-gaap/2024 | Accumulated other comprehensive loss | 0 |
| 0001599298-25-000089 | 2 | 32 | BS | 0 | H | Retained Earnings Accumulated Deficit | us-gaap/2024 | Accumulated deficit | 0 |
| 0001599298-25-000089 | 2 | 33 | BS | 0 | H | Stockholders Equity | us-gaap/2024 | Total stockholders' equity | 0 |
| 0001599298-25-000089 | 2 | 34 | BS | 0 | H | Liabilities And Stockholders Equity | us-gaap/2024 | Total liabilities and stockholders' equity | 0 |
| 0001599298-25-000089 | 3 | 1 | BS | 1 | H | Preferred Stock Par Or Stated Value Per Share | us-gaap/2024 | Preferred stock, par value (in dollars per share) | 0 |
| 0001599298-25-000089 | 3 | 2 | BS | 1 | H | Preferred Stock Shares Authorized | us-gaap/2024 | Preferred stock, shares authorized (in shares) | 0 |
| 0001599298-25-000089 | 3 | 3 | BS | 1 | H | Preferred Stock Shares Issued | us-gaap/2024 | Preferred stock, shares issued (in shares) | 0 |
| 0001599298-25-000089 | 3 | 4 | BS | 1 | H | Preferred Stock Shares Outstanding | us-gaap/2024 | Preferred stock, shares outstanding (in shares) | 0 |
| 0001599298-25-000089 | 3 | 5 | BS | 1 | H | Common Stock Par Or Stated Value Per Share | us-gaap/2024 | Common stock par value (in dollars per share) | 0 |
| 0001599298-25-000089 | 3 | 6 | BS | 1 | H | Common Stock Shares Authorized | us-gaap/2024 | Common stock, shares authorized (in shares) | 0 |
| 0001599298-25-000089 | 3 | 7 | BS | 1 | H | Common Stock Shares Issued | us-gaap/2024 | Common stock, shares issued (in shares) | 0 |
| 0001599298-25-000089 | 3 | 8 | BS | 1 | H | Common Stock Shares Outstanding | us-gaap/2024 | Common stock, shares, outstanding (in shares) | 0 |
| 0001599298-25-000089 | 4 | 2 | IS | 0 | H | Research And Development Expense Excluding Acquired In Process Cost | us-gaap/2024 | Research and development | 0 |
| 0001599298-25-000089 | 4 | 3 | IS | 0 | H | General And Administrative Expense | us-gaap/2024 | General and administrative | 0 |
| 0001599298-25-000089 | 4 | 4 | IS | 0 | H | Operating Expenses | us-gaap/2024 | Total operating expenses | 0 |
| 0001599298-25-000089 | 4 | 5 | IS | 0 | H | Nonoperating Income Expense | us-gaap/2024 | Other income | 0 |
| 0001599298-25-000089 | 4 | 6 | IS | 0 | H | Interest Expense Nonoperating | us-gaap/2024 | Interest expense | 1 |
| 0001599298-25-000089 | 4 | 7 | IS | 0 | H | Net Income Loss | us-gaap/2024 | Net loss | 0 |
| 0001599298-25-000089 | 4 | 9 | IS | 0 | H | Earnings Per Share Basic | us-gaap/2024 | Basic (in dollars per share) | 0 |
| 0001599298-25-000089 | 4 | 10 | IS | 0 | H | Earnings Per Share Diluted | us-gaap/2024 | Diluted (in dollars per share) | 0 |
| 0001599298-25-000089 | 4 | 12 | IS | 0 | H | Weighted Average Number Of Shares Outstanding Basic | us-gaap/2024 | Basic (in shares) | 0 |
| 0001599298-25-000089 | 4 | 13 | IS | 0 | H | Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2024 | Diluted (in shares) | 0 |
| 0001599298-25-000089 | 4 | 15 | IS | 0 | H | Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax | us-gaap/2024 | Foreign currency translation adjustments | 0 |
| 0001599298-25-000089 | 4 | 16 | IS | 0 | H | Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax | us-gaap/2024 | Unrealized (loss)/gains on short-term investments | 0 |
| 0001599298-25-000089 | 4 | 17 | IS | 0 | H | Comprehensive Income Net Of Tax | us-gaap/2024 | Comprehensive loss | 0 |
| 0001599298-25-000089 | 5 | 10 | EQ | 0 | H | Common Stock Shares Outstanding | us-gaap/2024 | Beginning balance (in shares) | 0 |
| 0001599298-25-000089 | 5 | 11 | EQ | 0 | H | Stockholders Equity | us-gaap/2024 | Beginning balance | 0 |
| 0001599298-25-000089 | 5 | 12 | EQ | 0 | H | Stock Issued During Period Shares Share Based Compensation | us-gaap/2024 | Issuance of common stock under stock purchase plans and exercise of stock options and warrants (in shares) | 0 |
| 0001599298-25-000089 | 5 | 13 | EQ | 0 | H | Stock Issued During Period Value Share Based Compensation | us-gaap/2024 | Issuance of common stock under stock purchase plans and exercise of stock options and warrants | 0 |
| 0001599298-25-000089 | 5 | 14 | EQ | 0 | H | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | us-gaap/2024 | Stock-based compensation | 0 |
| 0001599298-25-000089 | 5 | 15 | EQ | 0 | H | Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | us-gaap/2024 | Net other comprehensive loss | 0 |
| 0001599298-25-000089 | 5 | 16 | EQ | 0 | H | Net Income Loss | us-gaap/2024 | Net loss | 0 |
| 0001599298-25-000089 | 5 | 17 | EQ | 0 | H | Common Stock Shares Outstanding | us-gaap/2024 | Ending balance (in shares) | 0 |
| 0001599298-25-000089 | 5 | 18 | EQ | 0 | H | Stockholders Equity | us-gaap/2024 | Ending balance | 0 |
| 0001599298-25-000089 | 6 | 2 | CF | 0 | H | Net Income Loss | us-gaap/2024 | Net loss | 0 |
| 0001599298-25-000089 | 6 | 4 | CF | 0 | H | Accretion Amortization Of Discounts And Premiums Investments | us-gaap/2024 | Amortization of discount on short-term investments | 1 |
| 0001599298-25-000089 | 6 | 5 | CF | 0 | H | Foreign Currency Transaction Gain Loss Unrealized | us-gaap/2024 | Unrealized foreign exchange loss (gain) | 1 |
| 0001599298-25-000089 | 6 | 6 | CF | 0 | H | Depreciation | us-gaap/2024 | Depreciation | 0 |
| 0001599298-25-000089 | 6 | 7 | CF | 0 | H | Share Based Compensation | us-gaap/2024 | Stock-based compensation | 0 |
| 0001599298-25-000089 | 6 | 9 | CF | 0 | H | Increase Decrease In Prepaid Deferred Expense And Other Assets | us-gaap/2024 | Prepaid expenses and other current assets | 1 |
| 0001599298-25-000089 | 6 | 10 | CF | 0 | H | Increase Decrease In Other Noncurrent Assets | us-gaap/2024 | Other assets | 1 |
| 0001599298-25-000089 | 6 | 11 | CF | 0 | H | Increase Decrease In Accounts Payable | us-gaap/2024 | Accounts payable | 0 |
| 0001599298-25-000089 | 6 | 12 | CF | 0 | H | Increase Decrease In Accrued Liabilities | us-gaap/2024 | Accrued liabilities | 0 |
| 0001599298-25-000089 | 6 | 13 | CF | 0 | H | Increase Decrease In Other Current Liabilities | us-gaap/2024 | Other current liabilities | 0 |
| 0001599298-25-000089 | 6 | 14 | CF | 0 | H | Increase Decrease In Other Noncurrent Liabilities | us-gaap/2024 | Other long-term liabilities | 0 |
| 0001599298-25-000089 | 6 | 15 | CF | 0 | H | Increase Decrease In Employee Related Liabilities | us-gaap/2024 | Accrued compensation | 0 |
| 0001599298-25-000089 | 6 | 16 | CF | 0 | H | Increase Decrease In Operating Lease Liability | us-gaap/2024 | Operating lease right-of-use assets and lease liabilities, net | 0 |
| 0001599298-25-000089 | 6 | 17 | CF | 0 | H | Net Cash Provided By Used In Operating Activities | us-gaap/2024 | Net cash used in operating activities | 0 |
| 0001599298-25-000089 | 6 | 19 | CF | 0 | H | Payments To Acquire Property Plant And Equipment | us-gaap/2024 | Purchases of property and equipment | 1 |
| 0001599298-25-000089 | 6 | 20 | CF | 0 | H | Payments To Acquire Short Term Investments | us-gaap/2024 | Purchase of short-term investments | 1 |
| 0001599298-25-000089 | 6 | 21 | CF | 0 | H | Proceeds From Sale Maturity And Collection Of Shortterm Investments | us-gaap/2024 | Maturities and sales of short-term investments | 0 |
| 0001599298-25-000089 | 6 | 22 | CF | 0 | H | Net Cash Provided By Used In Investing Activities | us-gaap/2024 | Net cash provided by investing activities | 0 |
| 0001599298-25-000089 | 6 | 24 | CF | 0 | H | Proceeds From Warrant Exercises | us-gaap/2024 | Proceeds received related to the exercise of warrants | 0 |
| 0001599298-25-000089 | 6 | 25 | CF | 0 | H | Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options | us-gaap/2024 | Proceeds received related to employee stock awards and purchase plans | 0 |
| 0001599298-25-000089 | 6 | 26 | CF | 0 | H | Net Cash Provided By Used In Financing Activities | us-gaap/2024 | Net cash provided by financing activities | 0 |
| 0001599298-25-000089 | 6 | 27 | CF | 0 | H | Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | us-gaap/2024 | Effect of exchange rate changes on cash | 0 |
| 0001599298-25-000089 | 6 | 28 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | us-gaap/2024 | Increase (decrease) in cash and cash equivalents | 0 |
| 0001599298-25-000089 | 6 | 29 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | Cash, cash equivalents and restricted cash at beginning of period | 0 |
| 0001599298-25-000089 | 6 | 30 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | Cash, cash equivalents and restricted cash at end of period | 0 |
| 0001599298-25-000089 | 6 | 32 | CF | 0 | H | Cash And Cash Equivalents At Carrying Value | us-gaap/2024 | Cash and cash equivalents | 0 |
| 0001599298-25-000089 | 6 | 33 | CF | 0 | H | Restricted Cash Current | us-gaap/2024 | Restricted cash | 0 |
| 0001599298-25-000089 | 6 | 34 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | Cash, cash equivalents, and restricted cash | 0 |
| 0001599298-25-000089 | 6 | 36 | CF | 0 | H | Interest Paid Net | us-gaap/2024 | Cash paid for interest on related party promissory notes | 0 |
| 0001599298-25-000089 | 6 | 38 | CF | 0 | H | Right Of Use Asset Obtained In Exchange For Operating Lease Liability | us-gaap/2024 | Leased assets obtained in exchange for operating lease liabilities | 0 |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| report | Represents the report grouping. This field corresponds to the statement (stmt) field, which indicates the type of statement. The numeric value refers to the “R file” as posted on the EDGAR Web site. |
| line | Represents the tag’s presentation line order for a given report. Together with the statement and report field, presentation location, order and grouping can be derived. |
| stmt | The financial statement location to which the value of the “report” field pertains. |
| inpth | Value was presented “parenthetically” instead of in columns within the financial statements. For example: Receivables (net of allowance for bad debts of $200 in 2012) $700. |
| rfile | The type of interactive data file rendered on the EDGAR web site, H = .htm file, X = .xml file. |
| tag | The tag chosen by the filer for this line item. |
| version | The taxonomy identifier if the tag is a standard tag, otherwise adsh. |
| plabel | The text presented on the line item, also known as a “preferred” label. |
| negating | Flag to indicate whether the plabel is negating. |